1. Home
  2. ECF vs CINGW Comparison

ECF vs CINGW Comparison

Compare ECF & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECF
  • CINGW
  • Stock Information
  • Founded
  • ECF 1986
  • CINGW N/A
  • Country
  • ECF United States
  • CINGW United States
  • Employees
  • ECF N/A
  • CINGW 13
  • Industry
  • ECF Finance/Investors Services
  • CINGW Biotechnology: Pharmaceutical Preparations
  • Sector
  • ECF Finance
  • CINGW Health Care
  • Exchange
  • ECF Nasdaq
  • CINGW Nasdaq
  • Market Cap
  • ECF 136.5M
  • CINGW N/A
  • IPO Year
  • ECF N/A
  • CINGW 2021
  • Fundamental
  • Price
  • ECF $9.58
  • CINGW $0.04
  • Analyst Decision
  • ECF
  • CINGW
  • Analyst Count
  • ECF 0
  • CINGW 0
  • Target Price
  • ECF N/A
  • CINGW N/A
  • AVG Volume (30 Days)
  • ECF 57.7K
  • CINGW N/A
  • Earning Date
  • ECF 01-01-0001
  • CINGW N/A
  • Dividend Yield
  • ECF 6.42%
  • CINGW N/A
  • EPS Growth
  • ECF N/A
  • CINGW N/A
  • EPS
  • ECF 0.46
  • CINGW N/A
  • Revenue
  • ECF N/A
  • CINGW N/A
  • Revenue This Year
  • ECF N/A
  • CINGW N/A
  • Revenue Next Year
  • ECF N/A
  • CINGW N/A
  • P/E Ratio
  • ECF $17.61
  • CINGW N/A
  • Revenue Growth
  • ECF N/A
  • CINGW N/A
  • 52 Week Low
  • ECF $7.02
  • CINGW N/A
  • 52 Week High
  • ECF $8.91
  • CINGW N/A
  • Technical
  • Relative Strength Index (RSI)
  • ECF 42.15
  • CINGW N/A
  • Support Level
  • ECF $9.48
  • CINGW N/A
  • Resistance Level
  • ECF $9.93
  • CINGW N/A
  • Average True Range (ATR)
  • ECF 0.10
  • CINGW 0.00
  • MACD
  • ECF -0.06
  • CINGW 0.00
  • Stochastic Oscillator
  • ECF 18.18
  • CINGW 0.00

About ECF Ellsworth Growth and Income Fund Ltd.

Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: